United States· US:42806-603_4bde62db-14e4-fede-e063-6294a90a1391
Venlafaxine Hydrochloride
A venlafaxine product containing venlafaxine hydrochloride, registered in United States by Epic Pharma, LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Venlafaxine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06AX16 (venlafaxine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Venlafaxine · ATC N06AX16
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of venlafaxine costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.18 in United States to $1.67 in Switzerland — a ×9.3 gap.
- United States: $0.18 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Venlafaxine · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.67
- IT Italy$0.61
- ES Spain$0.48
- FR France$0.31
- US United States$0.18 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VENLAFAXINE HYDROCHLORIDE
- Manufacturer
- Epic Pharma, LLC
- Country
- United States (US)
- ATC code
- N06AX16
- ATC class
- Venlafaxine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1142806-603-05
- ndc1142806-603-09
- ndc1142806-603-30
- ndc114280660305500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42806-603-05)
- ndc11428066030990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42806-603-09)
- ndc11428066033030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42806-603-30)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
552 interactions on record for venlafaxine.
Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Venlafaxine · interactions on record
552 records
- 57 severe
- 298 moderate
- 3 minor
- 154 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Venlafaxine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEFECTIN ERVIATRIS HEALTHCARE LIMITED, Dublin
- SpainARAFAXINA RETARD 150 mg CAPSULAS DE LIBERACION PROLONGADA EFGArafarma Group S.A.
- United KingdomAlventa XL 150mg capsulesKrka UK Ltd
- ItalyEFEXORFARMA 1000 S.R.L.
- FinlandAlventaPro Auctore
- PolandAlventaDelfarma Sp. z o.o.
- BelgiumEfexor-Exel 150 mgViatris Healthcare
- NetherlandsEfexor XR 150, capsules met verlengde afgifte, hard, 150 mgMedcor Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Efectin Er, Velostad
- Belgium · Efexor-Exel, Venlafaxin Retard Sandoz
- Bulgaria · Eфектин Er, Алвента
- Cyprus · Efaxine, Efexor Xr
- Czechia · Argofan, Efectin Er
- Germany · Trevilor Retard, Venlafaxin 1 A Pharma
- Denmark · Efastad, Efexor Depot
- Estonia · Alventa, Efexor Xr
- Spain · Dislaven Retard, Dobupal
- Finland · Efexor Depot, Venlafaxin Krka
- France · Effexor L.P., Venlafaxine L.P. Teva Sante
- United Kingdom (Northern Ireland) · Apclaven Xl, Bonilux Xl
- Greece · Deprevix, Efexor Xr
- Croatia · Alventa, Velafax
- Hungary · Falven, Faxinev
- Ireland · Efexor Xl, Ireven
- Iceland · Efexor Depot, Velocin
- Italy · Efexor, Ixilania
- Lithuania · Alventa, Efexor Xr
- Luxembourg · Efexor-Exel, Venlafaxin Ratiopharm
- Latvia · Venlaxor
- Malta · Efexor Xl, Venlafaxine Aurobindo
- Netherlands · Efexor Xr, Venfalex Xr
- Norway · Efastad, Efexor Depot
- Poland · Alventa, Axyven
- Portugal · Efexor Xr, Genexin
- Romania · Alventa, Efectin Ep
- Sweden · Efastad, Efexor Depot
- Slovenia · Alventa, Efectin Er
- Slovakia · Alventa, Velaxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cea8737d-4947-41bf-a895-6ef79e81bc66 GET /v1/drugs/cea8737d-4947-41bf-a895-6ef79e81bc66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "VENLAFAXINE HYDROCHLORIDE",
"productndc": "42806-603",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA214654",
"marketing_category": "ANDA"
}See everything about venlafaxine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.